Financial News
Latest News about RVMD
Recent news which mentions RVMD
The Daily Biotech Pulse: MacroGenics Breast Cancer Drug Wins FDA Approval, Adcom Test Awaits Moderna, Virios To Make Wall Street Debut
December 17, 2020
From Benzinga
Stocks That Hit 52-Week Highs On Wednesday
December 16, 2020
From Benzinga
52 Biggest Movers From Yesterday
October 27, 2020
From Benzinga
11 Healthcare Stocks Moving In Monday's Intraday Session
October 26, 2020
From Benzinga
48 Stocks Moving In Monday's Mid-Day Session
October 26, 2020
From Benzinga
The Week Ahead In Biotech: Spectrum Pharma FDA Decision, Biogen And Abbott Earnings, Cancer Conference
October 18, 2020
From Benzinga
The Daily Biotech Pulse: FDA Nod For Osmotica, OptiNose Strikes Co-promotion Deal, Orphan Drug Designation For AnaptysBio
July 09, 2020
From Benzinga
5 Stocks To Watch For July 7, 2020
July 07, 2020
From Benzinga
68 Biggest Movers From Yesterday
June 24, 2020
From Benzinga
The Daily Biotech Pulse: Ayala IPO, Pluristem Starts Phase 2 Trial Of COVID Treatment, European Nod For Takeda
May 08, 2020
From Benzinga
Stocks That Hit 52-Week Highs On Thursday
May 07, 2020
From Benzinga
70 Biggest Movers From Yesterday
May 06, 2020
From Benzinga
The Daily Biotech Pulse: AbbVie, Allergan Agree On Divestments, Obalon Stops Obesity Balloon Sale, COVID-19 Updates
March 18, 2020
From Benzinga
From Benzinga
88 Stocks Moving In Friday's Mid-Day Session
March 13, 2020
From Benzinga
From Benzinga
Benzinga's Top Upgrades, Downgrades For March 9, 2020
March 09, 2020
From Benzinga
The Week Ahead In Biotech (March 8-14): Bristol-Myers Awaits FDA Nod For Liver Cancer Combo Therapy, Earnings Flow Continues
March 08, 2020
From Benzinga
The Daily Biotech Pulse: Trevana Pain Drug Resubmission Accepted For Review, Can-Fite To Explore Treatment For COVID-19
March 05, 2020
From Benzinga
The Daily Biotech Pulse: Gilead Kicks Off Coronavirus Drug Trials, Adcom Nod For Lily, FDA Approves Esperion's Lipid-Lowering Adjunctive Combo Therapy
February 27, 2020
From Benzinga
Investors Scrambled to Buy This Biotech IPO
February 21, 2020
From Motley Fool
The Daily Biotech Pulse: FDA Approves Baudax Bio's Non-Opioid Pain Drug, Aerie Rallies On Q4 Results, D-Day For Esperion
February 21, 2020
From Benzinga
The Daily Biotech Pulse: FDA Snub For Merck, Priority Review For Roche's Tecentriq sBLA
February 19, 2020
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
